|
Age at surgery (years)
| |
|
Median (IQR)
|
67 (27–85)
|
|
Gender, n (%)
| |
|
Male
|
79 (69)
|
|
Female
|
36 (31)
|
|
Serum albumin level (g/dl)
| |
|
Median (IQR)
|
4.1 (3.2–5.0)
|
|
ASA score, n (%)
| |
|
1
|
32 (28)
|
|
2
|
75 (65)
|
|
3
|
8 (7)
|
|
PNI
| |
|
Median (IQR)
|
47.7 (35.9–59.2)
|
|
CRP (mg/dl)
| |
|
Median (IQR)
|
0.90 (0.01–4.24)
|
|
mGPS, n (%)
|
0
|
|
0
|
93 (81)
|
|
1
|
18 (16)
|
|
2
|
4 (3)
|
|
BMI
| |
|
Median (IQR)
|
21.3 (14.7–30.4)
|
|
Primary tumour location, n (%)
| |
|
Colon
|
77 (67)
|
|
Rectum
|
38 (33)
|
|
Tumour location, n (%)
| |
|
Unilobe
|
16 (14)
|
|
Bilobe
|
99 (86)
|
|
Tumour size (mm)
| |
|
Median (IQR)
|
28 (5–120)
|
|
Number of tumours
| |
|
Median (IQR)
|
3 (1–30)
|
|
Detection of metastasis, n (%)
| |
|
Synchronous
|
60 (52)
|
|
Metachronous
| |
|
CEA (ng/dl)
| |
|
Median (IQR)
|
5.5 (1.1–855)
|
|
CA19-9 (mU/l)
| |
|
Median (IQR)
|
26 (1–2368)
|
|
Preoperative chemotherapy, n (%)
| |
|
Yes
|
71 (62)
|
|
No
|
44 (38)
|
|
Postoperative chemotherapy, n (%)
| |
|
Yes
|
48 (42)
|
|
No
|
67 (58)
|
|
Other organ metastasis at hepatectomy, n (%)
| |
|
Yes
|
20 (17)
|
|
Surgical margin, n (%)
| |
|
Positive
|
21 (18)
|
|
Negative
|
94 (82)
|
|
Surgical procedure, n (%)
| |
|
Major resection
|
34 (30)
|
|
Minor resection
|
81 (70)
|
|
Synchronous resection for primary tumour, n (%)
| |
|
Yes
|
9 (8)
|
|
Operation time (min)
| |
|
Median (IQR)
|
431 (198–797)
|
|
Operative blood loss (ml)
| |
|
Median (IQR)
|
524 (0–2257)
|
|
Postoperative complications, n (%)
| |
|
Clavien-Dindo grade II
|
20 (17)
|
|
Clavien-Dindo grade III or IV
|
12 (10)
|
